MapLight Therapeutics
The Director, Regulatory Affairs leads global regulatory strategy for neuroscience programs, develops regulatory strategies for product candidates, and coordinates with cross-functional teams and regulatory agencies.
MapLight Therapeutics is a biotechnology company focused on redefining the standard of care for brain disorders through targeted CNS treatments. The company leverages a proprietary discovery platform combining optogenetics, STARmap, and transcriptomics to identify and target individual neural circuits that misfire in brain disorders. Its clinical pipeline includes compounds for schizophrenia, Alzheimer's disease psychosis, and autism spectrum disorder, while its preclinical pipeline addresses Parkinson's disease, hyperactivity, and impulsivity.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MapLight Therapeutics.
Executive Director, Global Regulatory Lead
Perspective Therapeutics
Regulatory Professional - Regulatory Affairs
State of Indiana
Associate Director, Regulatory Affairs - Development Strategy
Insmed Incorporated
Manager, CMC Regulatory Affairs
Capricor Therapeutics
Associate Director, CMC Regulatory Affairs
Vertex
Senior Manager, Regulatory Affairs CMC
Spyre Therapeutics